Next Article in Journal
The Role of Extracellular Matrix in Skin Wound Healing
Next Article in Special Issue
Cellular Processes in Human Ovarian Follicles Are Regulated by Expression Profile of New Gene Markers—Clinical Approach
Previous Article in Journal
Specific versus Non-Specific Exercises for Chronic Neck or Shoulder Pain: A Systematic Review
Previous Article in Special Issue
Impact of the Vaginal and Endometrial Microbiome Pattern on Assisted Reproduction Outcomes
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
JCM
Volume 10
Issue 24
10.3390/jcm10245945
jcm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

The Association between Bisphenol A, Steroid Hormones, and Selected MicroRNAs Levels in Seminal Plasma of Men with Infertility

by
Ewelina Palak
1,
Weronika Lebiedzińska
2,
Sławomir Anisimowicz
3,
Maria Sztachelska
1,
Piotr Pierzyński
4,
Wiesław Wiczkowski
5,
Beata Żelazowska-Rutkowska
6,
Gabriella Nicole Niklińska
7,
Donata Ponikwicka-Tyszko
1 and
Sławomir Wołczyński
1,2,*
1
Department of Biology and Pathology of Human Reproduction, Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, 10-748 Olsztyn, Poland
2
Department of Reproduction and Gynecological Endocrinology, Medical University of Bialystok, 15-089 Białystok, Poland
3
Gynecology and Reproductive Endocrinology Centre ARTemida, 15-464 Białystok, Poland
4
Oviclinic, 01-377 Warsaw, Poland
5
Department of Chemistry and Biodynamics of Food, Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, 10-748 Olsztyn, Poland
6
Department of Pediatric Laboratory Diagnostic, Medical University of Bialystok, 15-089 Białystok, Poland
7
Sluzewiec Equine Hospital, 02-684 Warsaw, Poland
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2021, 10(24), 5945; https://doi.org/10.3390/jcm10245945
Submission received: 27 October 2021 / Revised: 13 December 2021 / Accepted: 15 December 2021 / Published: 18 December 2021
(This article belongs to the Special Issue Updates in Diagnosis and Treatment of Infertility)
Browse Figures
Versions Notes

Abstract

:
Bisphenol A (BPA), the most common endocrine-disrupting chemical, has been associated with male reproductive dysfunctions. Recently, it has been shown that BPA may also affect miRNAs expression. Herein, we aimed to evaluate the association of BPA levels with steroid hormone concentration and circulating miRNAs levels to investigate the potential direct effect of BPA on homeostasis in the testis environment. The level of BPA in the seminal plasma of azoospermic men was significantly higher compared to the healthy control. The concentrations of estradiol (E2) and androstenedione (A) were significantly decreased in the seminal plasma of azoospermic men compared to the normospermic men. The levels of miR-let-7a, miR-let-7b, and miR-let-7c were significantly up-regulated, and the level of miR-518f was significantly down-regulated in the seminal plasma of the azoospermic men compared to the healthy control. The level of BPA correlated negatively with sperm concentration and normal semen morphology. A significant positive correlation was found between BPA levels and miR-let-7a and miR-let-7c levels, whereas BPA negatively correlated with miR-518f levels. Our results suggest that BPA may negatively affect sperm quality. Moreover, BPA correlated with the miR-let-7a, miR-let-7c, and miR-518f levels in seminal plasma, which suggests that BPA may act directly in seminal plasma, affecting the testicular environment.

1. Introduction

Bisphenol A (BPA) is the most common industrial plasticizer classified as an endocrine disrupting-chemical (EDC) [1]. BPA has been found in many plastic products and epoxy resins and has the ability to easily leach into food [2,3]. BPA enters the body through the digestive system, skin contact [4], and inhalation [5], and its presence has been detected in different tissues, serum, urine, seminal plasma, follicular fluid, and umbilical cord plasma [6,7,8]. Exposure to BPA has been shown to have a negative impact on human health, including male reproduction and fertility [7,9,10]. However, studies evaluating the effects of BPA on sperm quality parameters and/or sex hormone levels have been inconsistent [7,11,12,13,14,15,16,17,18].
BPA may alter the function of the hypothalamic–pituitary–testicular axis and cause testicular dysgenesis and atrophy, enlargement of the prostate gland, and changes in semen parameters [9,10,19]. It has been shown that BPA binds with weak affinity to nuclear estrogen receptors (ER) [20] and binds to membrane estrogen receptors [21] with a similar affinity to estradiol (E2). BPA may also exert its effect through the androgen receptors [22], estrogen-related receptors [23], thyroid receptors [24], or glucocorticoid receptors [25]. However, BPA action is not limited to hormonal receptors, but it can also induce several epigenetic modifications in both animals and humans through DNA methylation, histone modifications, and the alteration of microRNA (miRNA) levels [26,27].
MiRNAs are non-coding, single-stranded RNA molecules composed of 18–24 nucleotides [28]. They are important regulators of post-transcriptional gene expression, and they achieve this via translational repression or mRNA degradation in mammals [29]. MiRNAs can be found in a number of different tissues and body fluids, including the testis, sperm, and seminal plasma, and may regulate spermatogenesis, sperm maturation, and capacitation [30,31]. The synthesis and expression of miRNA may be regulated by hormonal signaling [32]. Furthermore, circulating miRNAs may present differential levels under the effects of different toxicants [33]. Differential patterns of miRNAs expression were also induced by EDCs including BPA [27,34]; however, the BPA action in epigenetic modulation is still unclear.
Although the effect of BPA on reproductive tissues is the topic of recent extensive research, there are limited data on how BPA affects the reproductive tissues environment. Seminal plasma is a unique body fluid that creates the environment in which the effects of BPA may be expressed directly in testicular tissue. Herein, we aimed to evaluate the association of BPA levels with steroid hormone concentration and circulating miRNAs levels to investigate the potential direct effect of BPA on homeostasis in the testis environment. The miRNAs chosen for this study were miR-let-7a, miR-let-7b, miR-let-7c, and miR-518f as they have been associated with estrogen and androgen signaling [35,36]. Moreover, we also investigated the possible associations of seminal plasma BPA levels with sperm quality parameters.

2. Materials and Methods

2.1. Study Participants

The study group comprised of patients recruited in the Department of Reproduction and Gynecological Endocrinology at the Medical University of Bialystok, Poland. The Human Investigation Ethics Committees at the Medical University of Bialystok approved the study. Written informed consent was obtained from all patients prior to inclusion. A total of 116 men with non-obstructive azoospermia (n = 20), oligoasthenoteratozoospermia (n = 46), and control normospermic (n = 50) were enrolled in this study. The mean age and BMI of the men were similar in all groups (Table 1). All of the men included in the study came from cities and had not had high levels of occupational exposure to BPA. Men with pathologies of the epididymis or vas deferens, cryptorchidism, mumps, varicocele, retrograde ejaculation, chromosomal abnormalities, and Y chromosome microdeletions were excluded from the study. Smokers and men who regularly consumed alcohol were also excluded from the study. The controls were healthy men with normal sperm parameters who had fathered at least one healthy child within the past year without assisted reproductive techniques. Patients underwent a standardized ejaculate examination according to the World Health Organization (WHO) criteria. Samples were collected using BPA-free glass equipment. Semen samples were centrifuged for 5 min at 1500× g to collect seminal plasma, aliquoted and stored in BPA-free tubes at –80 °C until further analysis.

2.2. Semen Analysis

The semen samples were obtained in a private room after a recommended 2–5 days of sexual abstinence. Semen analyses were conducted after liquefaction at 37 °C for 30 min by the micro-cell slide and the computer-aided semen analysis (CASA, version 6.3-SCA®, Microptic, S.L., Barcelona, Spain) in accordance with WHO guidelines (World Health Organization. (2010)). WHO laboratory manual for the examination and processing of human semen, 5th ed. World Health Organization. A minimum of 200 sperm cells from at least four different fields were analyzed from each specimen. Each sample was assessed twice. Measured semen parameters included semen volume, sperm concentration, total sperm count, and sperm motility. Sperm morphology was evaluated using the Diff-Quik staining set (Medion Grifols Diagnostics AG, Düdingen, Switzerland). Total sperm count (106) was calculated by multiplying sperm concentration (106/mL) by semen sample volume (mL).

2.3. BPA Measurement from the Seminal Plasma Samples

Bisphenol A was measured from seminal plasma samples that were thawed at room temperature. BPA was extracted from the samples three times, using sonication in acetonitrile and vortex mixing. The collected supernatants were first centrifuged for 10 min at 5000× g and then evaporated at 37 °C under a nitrogen atmosphere until complete solvent evaporation. The formed solids were then dissolved in methanol and injected into UHPLC microcolumns coupled with a mass spectrometer (TripleTOF 5600 + mass spectrometer, AB SCIEX, Framingham, MA, USA). Deuterated BPA was used as an internal standard. The BPA concentrations were calculated using a calibration curve for concentrations from 0 to 4.3 nmol/L.

2.4. Biochemical Analyses

Estradiol, progesterone, and testosterone levels were measured by the immunoanalyzer Cobas e411 (Roche Diagnostic Ltd., Basel, Switzerland) using the Elecsys Estradiol III Gen Kit (#06656021190; Roche Diagnostic Ltd., Basel, Switzerland), the Elecsys Progesterone II Gen Kit (#12145383 190; Roche Diagnostic Ltd., Basel, Switzerland), and the Elecsys testosterone II Gen Kit (#05200067190; Roche Diagnostic Ltd., Basel, Switzerland). Androstenedione concentrations were measured by the immunoanalyzer IMMULITE 1000 (Siemens Healthcare Diagnostics, Chicago, IL, USA) using the IMMULITE 1000 Androstenedione kit (#LKAO1; Siemens Healthcare Diagnostics, Chicago, IL, USA).

2.5. Total RNA Isolation

The total RNA was isolated from the seminal plasma using the TRIzol extraction method (Invitrogen, Carlsbad, CA, USA). Three purification steps were added. To achieve technical normalization, all samples were spiked with synthetic non-human C. elegans cel-miR-39 (Integrated DNA Technologies, Coralville, IA, USA). The synthetic cel-miR-39 was reconstituted in nuclease-free water (Ambion, Austin, TX, USA), resulting in a 2 × 1010 copies/μL stock. Next, the working solution was prepared to provide 1.6 × 108 copies/μL solution. To all samples, 3.5 μL of the cel-miR-39 working solution was added. The RNA concentration was measured using a NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, USA), while its quality was verified by denaturing agarose gel electrophoresis.

2.6. MicroRNA Analysis

cDNA synthesis was performed using the TaqMan®MicroRNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA, USA). The reaction was performed with 5 ng of total RNA in a total volume of 15 μL. The mixture was incubated at 16 °C for 30 min, 42 °C for 30 min, and 85 °C for 5 min as recommended by the manufacturer. TaqMan miRNA probes (cel-miR-39, # 000200; U6 snRNA, # 001973; miR-518f-3p, # 002388; miR-let-7a-5p; # 000377; miR-let-7b-5p, # 002619; miR-let-7c-3p; # 002479; Applied Biosystems) were used to assess the selected miRNA expression profile. Real-time PCR assays were performed in a total of 20 μL reaction volume with TaqMan Universal PCR Master Mix, No AmpErase UNG (Applied Biosystems). Each sample was processed in doublets with an initial denaturation at 95 °C for 10 min followed by 40 amplification cycles at 95 °C for 15 s and 60 °C for 60 s using the 7500 Real-Time PCR System (Applied Biosystems). The miRNA Ct-values were normalized using the exogenous cel-miR-39 and endogenous U6 snRNA. After the reactions, the Ct data were determined using default threshold settings and the mean Ct was determined from the duplicate PCRs. The expression of miRNA relative to U6 snRNA was determined using the 2−ΔCt method.

2.7. Statistical Analysis

Statistical analyses were conducted using GraphPad Prism 9 (GraphPad Software, San Diego, CA, USA). Due to non-normal distribution of data, the non-parametric Kruskal–Wallis test with Dunn’s post hoc test was applied in the analysis. The correlations between the studied parameters were assessed with Spearman’s correlation coefficient. Statistical significance was assumed at p < 0.05.

3. Results

No significant differences in age and BMI were observed between men with oligoasthenoteratozoospermia, men with azoospermia, and the control (Table 1). The level of BPA in the seminal plasma was significantly higher in the group of men with azoospermia compared to the control group of healthy men (Figure 1). No difference in seminal plasma BPA levels was observed between the group of men with oligoasthenoteratozoospermia compared to the control (Figure 1).
The level of E2 was significantly decreased in the seminal plasma of the group of men with azoospermia compared to the control (Figure 2a). There were no significant differences in the P4 and T concentrations in the seminal plasma of the group of men with azoospermia, oligoasthenoteratozoospermia, and the control (Figure 2b,c). The concentration of A was significantly lower in the seminal plasma of the group of men with azoospermia compared to the control (Figure 2d). The ratio of E2 to T in the control, oligoasthenoteratozoospermia, and azoospermia groups was 62.56 ± 12.35, 51.44 ± 6.38, and 65.45 ± 15.92, respectively.
We observed higher levels of circulating miR-let-7a, miR-let-7b, and miR-let-7c in the seminal plasma of the group of men with azoospermia compared to the control (Figure 3a–c). No differences in the seminal plasma levels of miR-let-7a, miR-let-7b, and miR-let-7c were found between the group of men with oligoasthenoteratozoospermia compared to the control (Figure 3a–c). The level of miR-518f was significantly down-regulated in the seminal plasma of men with azoospermia compared to the control (Figure 3d). There was no significant difference in the miR-518f levels in the seminal plasma of men with oligoasthenoteratozoospermia compared to the control (Figure 3d).
The level of BPA correlated negatively with sperm concentration, total sperm concentration, and normal semen morphology (r = −0.232, p = 0.01, r = −0.22, p = 0.02 and r = −0.193, p = 0.04; respectively) (Table 2). Significant positive correlation was found between BPA levels and miR-let-7a and miR-let-7c levels (r = 0.189, p = 0.04 and r = 0.249, p = 0.007; respectively) (Table 2). The level of BPA correlated negatively with miR-518f levels (r = −0.236, p = 0.01) (Table 2). No correlations were observed between BPA levels and total and progressive motility, steroid hormone and miR-let-7b levels (Table 2).

4. Discussion

BPA exposure has been associated with adverse effects on male reproductive functions, spermatogenesis, and fertility [37,38]. In this study, we showed that higher BPA seminal plasma levels were associated with azoospermia. Previously, high urinary levels of BPA have also been correlated with sexual dysfunction, greater erectile and ejaculatory problems, and decreased sperm concentration and motility [12,39]. Urinary BPA concentration has also had a positive association with sperm DNA damage [40]. However, some studies showed no significant association between BPA urinary levels and altered semen quality parameters [13,41]. We found a negative correlation between BPA seminal plasma levels, sperm concentration, and normal sperm morphology. Our results are consistent with other studies that show that only seminal plasma BPA was negatively associated with sperm concentration, sperm count, and morphology [7,38]. These discrepancies may occur due to different biological fluids being used to measure BPA levels. However, as seminal plasma represents the testicular environment, it seems to be the most applicable biological fluid to assess the impact of BPA on semen parameters. It has been shown that the BPA concentration in blood plasma positively correlated with BPA levels in seminal plasma, but only BPA seminal plasma concentration negatively correlated with semen parameters [7]. Previous studies showed that BPA levels depend on the living environment and the workplace of the studied patients [17,42]. The BPA serum levels were significantly higher in the men living in metropolitan areas than the men living in urban and rural areas [42]. The level of BPA was also significantly higher in infertile men compared to fertile men [42]. Another study showed that the serum levels of BPA in factory workers were significantly increased, which was associated with disordered male sex hormone levels [17]. In our study, all patients came from urban areas and had not had high levels of occupational exposure to BPA.
Since estrogens play an important role in testicular spermatogenesis, several studies have investigated the impact of BPA on estrogen levels and estrogen metabolism [7,13,38]. A significant positive correlation between urinary BPA and E2 plasma levels has been shown in a group of young men [13]. Blood plasma and seminal plasma BPA levels were also positively associated with E2 concentration in infertile men [7,38]. However, some studies showed either no association between urinary BPA and E2 levels [14] or an inverse association [15]. In our studies, we did not find a correlation between BPA seminal plasma levels and estrogens or other steroids; however, the concentration of E2 and A in the seminal plasma of azoospermic men was decreased.
Recently, aberrant miRNAs expression in testicular tissue has been reported [43]. Alterations of the miRNA levels have also been found in biological fluids such as seminal plasma [44,45]. These altered levels of circulating miRNA have been associated with male infertility [44,45]. In our studies, in azoospermic men, we found increased seminal plasma levels of miR-let-7a, miR-let-7b, and miR-let-7c, but decreased seminal plasma levels of miR-518f. The miR-let-7 family represents the most abundant miRNAs present in the testis that may regulate the cell cycle and proliferation [46], but the exact functions are still not fully understood. Our results are in line with other studies that showed a higher level of miR-let-7a in seminal plasma of azoospermic, asthenozoospermic or oligozoospermic men [31,45]. However, in the seminal plasma of asthenozoospermic men, the level of miR-let-7b was decreased but increased in sperm from infertile men [47,48]. Similarly, in infertile men a decreased level of miR-518f has been reported [48]. The level of miR-518f was also increased in the follicular fluid of hyperandrogenic women with polycystic ovary syndrome [36]. In our studies, we found a decreased level of miR-518f in the seminal plasma of azoospermic men who also had decreased levels of androstenedione. We also found a positive correlation between BPA concentration and miR-let-7a and miR-let-7c levels and a negative correlation between BPA concentration and miR-518f levels in seminal plasma. It has been shown that in human breast cancer cells, BPA may influence estrogen receptor activity and down-regulate miR-let-7 expression [27]. Moreover, the miR-let-7 family seems to be under the control of E2, as the expression of eight members of the miR-let-7 family showed to be up-regulated by E2 in breast cancer cells [35]. An in vivo study on a sheep model showed that BPA down-regulated expression of 45 miRNAs in the fetal ovary, including miR-let-7 family members and up-regulated Cyp19 expression [49]. The predicted bioinformatic functional analysis also showed that Cyp19 might be a target gene for the miR-let-7 family [49]. Moreover, it has been shown that in the endometrial cells from women with endometriosis, inhibition of aromatase significantly increased the expression of miR-let-7 [50]. Thus, it is possible that BPA may regulate the Cyp19 expression through miR-let-7 epigenetic mechanisms [49]. However, the potential molecular mechanism of BPA-CYP19-miR-let-7 signaling is still unknown. It seems that in the seminal plasma and testis, BPA may also affect the miR-let-7 family expression and affect estrogen and androgen signaling; however, the data pertaining to the miR-let-7 family function in testis remain very limited.

5. Conclusions

In conclusion, our findings showed that BPA may have different concentrations in seminal plasma and may negatively correlate with sperm quality parameters. It seems that BPA may act directly in seminal plasma, thus affecting the testicular environment and the levels of hormones and miRNAs. However, the exact direct mechanism of BPA action and its interaction with miRNAs in seminal plasma requires further investigation.

Author Contributions

E.P., D.P.-T. and S.W. designed the study concept; E.P., W.L., S.A., P.P., W.W., B.Ż.-R., M.S. and G.N.N. acquired the data and interpreted the results; E.P. and S.W. drafted the manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

This work was financially supported by the Polish National Science Center Grant 2012/05/B/NZ7/02391 (S.W.), Medical University of Bialystok Grant SUB/1/DN/21/001/1104 (S.W.), and European Union EU PARP Grant Cluster “NCREMFP” UDA-POIG.05.01.00-005/12-00 (S.W.).

Institutional Review Board Statement

The study was approved by the Ethics Committee at the Medical University of Bialystok (R-I-002/148/2018).

Informed Consent Statement

Written informed consent had been obtained from all patients prior to inclusion.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Sharpe, R.M.; Irvine, D.S. How Strong Is the Evidence of a Link between Environmental Chemicals and Adverse Effects on Human Reproductive Health? BMJ 2004, 328, 447–451. [Google Scholar] [CrossRef] [Green Version]
  2. Rochester, J.R. Bisphenol A and Human Health: A Review of the Literature. Reprod. Toxicol. 2013, 42, 132–155. [Google Scholar] [CrossRef]
  3. Vandenberg, L.N.; Hauser, R.; Marcus, M.; Olea, N.; Welshons, W.V. Human Exposure to Bisphenol A (BPA). Reprod. Toxicol. 2007, 24, 139–177. [Google Scholar] [CrossRef] [PubMed]
  4. Toner, F.; Allan, G.; Dimond, S.S.; Waechter, J.M.; Beyer, D. In Vitro Percutaneous Absorption and Metabolism of Bisphenol A (BPA) through Fresh Human Skin. Toxicol. Vitr. 2018, 47, 147–155. [Google Scholar] [CrossRef]
  5. Hines, C.J.; Jackson, M.V.; Christianson, A.L.; Clark, J.C.; Arnold, J.E.; Pretty, J.R.; Deddens, J.A. Air, Hand Wipe, and Surface Wipe Sampling for Bisphenol A (BPA) among Workers in Industries that Manufacture and Use BPA in the United States. J. Occup. Environ. Hyg. 2017, 14, 882–897. [Google Scholar] [CrossRef] [PubMed]
  6. Ikezuki, Y.; Tsutsumi, O.; Takai, Y.; Kamei, Y.; Taketani, Y. Determination of Bisphenol A Concentrations in Human Biological Fluids Reveals Significant Early Prenatal Exposure. Hum. Reprod. 2002, 17, 2839–2841. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  7. Vitku, J.; Sosvorova, L.; Chlupacova, T.; Hampl, R.; Hill, M.; Sobotka, V.; Heracek, J.; Bicikova, M.; Stárka, L. Differences in Bisphenol A and Estrogen Levels in the Plasma and Seminal Plasma of Men with Different Degrees of Infertility. Physiol. Res. 2015, 64, S303–S311. [Google Scholar] [CrossRef]
  8. Lukasiewicz, M.; Czerniecki, J.; Ponikwicka-Tyszko, D.; Sztachelska, M.; Hryniewicka, M.; Nalewajko-Sieliwoniuk, E.; Wiczkowski, W.; Banaszewska, B.; Milewski, R.; Toppari, J.; et al. Placenta Is Capable of Protecting the Male Fetus from Exposure to Environmental Bisphenol A. Expo. Health 2020, 13, 1–14. [Google Scholar] [CrossRef]
  9. LaRocca, J.; Boyajian, A.; Brown, C.; Smith, S.D.; Hixon, M. Effects of In Utero Exposure to Bisphenol A or Diethylstilbestrol on the Adult Male Reproductive System. Birth Defects Res. Part B Dev. Reprod. Toxicol. 2011, 92, 526–533. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  10. Jin, P.; Wang, X.; Chang, F.; Bai, Y.; Li, Y.; Zhou, R.; Chen, L. Low Dose Bisphenol A Impairs Spermatogenesis by Suppressing Reproductive Hormone Production and Promoting Germ Cell Apoptosis in Adult Rats. J. Biomed. Res. 2013, 27, 135–144. [Google Scholar] [CrossRef]
  11. Mendiola, J.; Jørgensen, N.; Andersson, A.-M.; Calafat, A.M.; Ye, X.; Redmon, J.B.; Drobnis, E.Z.; Wang, C.; Sparks, A.; Thurston, S.W.; et al. Are Environmental Levels of Bisphenol A Associated with Reproductive Function in Fertile Men? Environ. Health Perspect. 2010, 118, 1286–1291. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Li, D.-K.; Zhou, Z.; Miao, M.; He, Y.; Wang, J.; Ferber, J.; Herrinton, L.J.; Gao, E.; Yuan, W. Urine Bisphenol-A (BPA) Level in Relation to Semen Quality. Fertil. Steril. 2011, 95, 625–630.e4. [Google Scholar] [CrossRef]
  13. Lassen, T.H.; Frederiksen, H.; Jensen, T.K.; Petersen, J.H.; Joensen, U.N.; Main, K.M.; Skakkebaek, N.E.; Juul, A.; Jørgensen, N.; Andersson, A.-M. Urinary Bisphenol A Levels in Young Men: Association with Reproductive Hormones and Semen Quality. Environ. Health Perspect. 2014, 122, 478–484. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Galloway, T.; Cipelli, R.; Guralnik, J.; Ferrucci, L.; Bandinelli, S.; Corsi, A.M.; Money, C.; McCormack, P.; Melzer, D. Daily Bisphenol A Excretion and Associations with Sex Hormone Concentrations: Results from the InCHIANTI Adult Population Study. Environ. Health Perspect. 2010, 118, 1603–1608. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Meeker, J.D.; Calafat, A.M.; Hauser, R. Urinary Bisphenol A Concentrations in Relation to Serum Thyroid and Reproductive Hormone Levels in Men from an Infertility Clinic. Environ. Sci. Technol. 2010, 44, 1458–1463. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Zhou, Q.; Miao, M.; Ran, M.; Ding, L.; Bai, L.; Wu, T.; Yuan, W.; Gao, E.; Wang, J.; Li, G.; et al. Serum Bisphenol-A concentration and Sex Hormone Levels in Men. Fertil. Steril. 2013, 100, 478–482. [Google Scholar] [CrossRef] [PubMed]
  17. Zhuang, W.; Wu, K.; Wang, Y.; Zhu, H.; Deng, Z.; Peng, L.; Zhu, G. Association of Serum Bisphenol-A Concentration and Male Reproductive Function among Exposed Workers. Arch. Environ. Contam. Toxicol. 2014, 68, 38–45. [Google Scholar] [CrossRef]
  18. Kim, E.J.; Lee, D.; Chung, B.C.; Pyo, H.; Lee, J. Association between Urinary Levels of Bisphenol-A and Estrogen Metabolism in Korean Adults. Sci. Total Environ. 2014, 470–471, 1401–1407. [Google Scholar] [CrossRef]
  19. Nakamura, D.; Yanagiba, Y.; Duan, Z.; Ito, Y.; Okamura, A.; Asaeda, N.; Tagawa, Y.; Li, C.; Taya, K.; Zhang, S.-Y. Bisphenol A May Cause Testosterone Reduction by Adversely Affecting Both Testis and Pituitary Systems Similar to Estradiol. Toxicol. Lett. 2010, 194, 16–25. [Google Scholar] [CrossRef] [PubMed]
  20. Gould, J.C.; Leonard, L.S.; Maness, S.C.; Wagner, B.L.; Conner, K.; Zacharewski, T.; Safe, S.; McDonnell, D.P.; Gaido, K.W. Bisphenol A Interacts with the Estrogen Receptor α in a Distinct Manner from Estradiol. Mol. Cell. Endocrinol. 1998, 142, 203–214. [Google Scholar] [CrossRef]
  21. Alonso-Magdalena, P.; Ropero, A.B.; Soriano, S.; García-Arévalo, M.; Ripoll, C.; Fuentes, E.; Quesada, I.; Nadal, Á. Bisphenol-A Acts as a Potent Estrogen via Non-Classical Estrogen Triggered Pathways. Mol. Cell. Endocrinol. 2012, 355, 201–207. [Google Scholar] [CrossRef]
  22. Lee, H.J.; Chattopadhyay, S.; Gong, E.-Y.; Ahn, R.S.; Lee, K. Antiandrogenic Effects of Bisphenol A and Nonylphenol on the Function of Androgen Receptor. Toxicol. Sci. 2003, 75, 40–46. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Okada, H.; Tokunaga, T.; Liu, X.; Takayanagi, S.; Matsushima, A.; Shimohigashi, Y. Direct Evidence Revealing Structural Elements Essential for the High Binding Ability of Bisphenol A to Human Estrogen-Related Receptor-γ. Environ. Health Perspect. 2008, 116, 32–38. [Google Scholar] [CrossRef] [PubMed]
  24. Moriyama, K.; Tagami, T.; Akamizu, T.; Usui, T.; Saijo, M.; Kanamoto, N.; Hataya, Y.; Shimatsu, A.; Kuzuya, H.; Nakao, K. Thyroid Hormone Action Is Disrupted by Bisphenol A as an Antagonist. J. Clin. Endocrinol. Metab. 2002, 87, 5185–5190. [Google Scholar] [CrossRef]
  25. Sargis, R.M.; Johnson, D.N.; Choudhury, R.A.; Brady, M.J. Environmental Endocrine Disruptors Promote Adipogenesis in the 3T3-L1 Cell Line through Glucocorticoid Receptor Activation. Obesity 2010, 18, 1283–1288. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Skinner, M.K. Environmental Epigenomics and Disease Susceptibility. EMBO Rep. 2011, 12, 620–622. [Google Scholar] [CrossRef] [Green Version]
  27. Tilghman, S.L.; Bratton, M.; Segar, H.C.; Martin, E.C.; Rhodes, L.; Li, M.; McLachlan, J.A.; Wiese, T.E.; Nephew, K.P.; Burow, M.E. Endocrine Disruptor Regulation of MicroRNA Expression in Breast Carcinoma Cells. PLoS ONE 2012, 7, e32754. [Google Scholar] [CrossRef] [PubMed]
  28. Berezikov, E. Evolution of MicroRNA Diversity and Regulation in Animals. Nat. Rev. Genet. 2011, 12, 846–860. [Google Scholar] [CrossRef]
  29. Bartel, D.P. MicroRNAs: Target Recognition and Regulatory Functions. Cell 2009, 136, 215–233. [Google Scholar] [CrossRef] [Green Version]
  30. Salas-Huetos, A.; James, E.R.; Aston, K.I.; Carrell, D.T.; Jenkins, T.G.; Yeste, M. The Role of miRNAs in Male Human Reproduction: A Systematic Review. Andrology 2019, 8, 7–26. [Google Scholar] [CrossRef] [Green Version]
  31. Mokánszki, A.; Molnár, Z.; Tóthné, E.V.; Bodnár, B.; Jakab, A.; Bálint, B.L.; Balogh, I. Altered MicroRNAs Expression Levels of Sperm and Seminal Plasma in Patients with Infertile Ejaculates Compared with Normozoospermic Males. Hum. Fertil. 2019, 23, 246–255. [Google Scholar] [CrossRef] [PubMed]
  32. Katchy, A.; Williams, C. Expression Profiles of Estrogen-Regulated MicroRNAs in Breast Cancer Cells. In Estrogen Receptors. Methods in Molecular Biology; Humana Press: New York, NY, USA, 2016; Volume 1366, pp. 373–393. [Google Scholar] [CrossRef] [Green Version]
  33. Schraml, E.; Hackl, M.; Grillari, J. MicroRNAs and Toxicology: A Love Marriage. Toxicol. Rep. 2017, 4, 634–636. [Google Scholar] [CrossRef]
  34. Kim, J.H.; Cho, Y.H.; Hong, Y.-C. MicroRNA Expression in Response to Bisphenol A Is Associated with High Blood Pressure. Environ. Int. 2020, 141, 105791. [Google Scholar] [CrossRef]
  35. Bhat-Nakshatri, P.; Wang, G.; Collins, N.R.; Thomson, M.J.; Geistlinger, T.R.; Carroll, J.S.; Brown, M.; Hammond, S.; Srour, E.F.; Liu, Y.; et al. Estradiol-Regulated MicroRNAs Control Estradiol Response in Breast Cancer Cells. Nucleic Acids Res. 2009, 37, 4850–4861. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Sørensen, A.; Wissing, M.L.; Englund, A.L.M.; Dalgaard, L. MicroRNA Species in Follicular Fluid Associating with Polycystic Ovary Syndrome and Related Intermediary Phenotypes. J. Clin. Endocrinol. Metab. 2016, 101, 1579–1589. [Google Scholar] [CrossRef] [Green Version]
  37. Manfo, F.P.T.; Jubendradass, R.; Nantia, E.A.; Moundipa, P.F.; Mathur, P.P. Adverse Effects of Bisphenol A on Male Reproductive Function. In Reviews of Environmental Contamination and Toxicology Volume 228. Reviews of Environmental Contamination and Toxicology (Continuation of Residue Reviews); Springer: Cham, Switzerland, 2013; pp. 57–82. [Google Scholar] [CrossRef]
  38. Vitku, J.; Heracek, J.; Sosvorova, L.; Hampl, R.; Chlupacova, T.; Hill, M.; Sobotka, V.; Bicikova, M.; Stárka, L. Associations of Bisphenol A and Polychlorinated Biphenyls with Spermatogenesis and Steroidogenesis in Two Biological Fluids from MEN Attending an Infertility Clinic. Environ. Int. 2016, 89–90, 166–173. [Google Scholar] [CrossRef] [PubMed]
  39. Li, D.-K.; Zhou, Z.; Miao, M.; He, Y.; Qing, D.; Wu, T.; Wang, J.; Weng, X.; Ferber, J.; Herrinton, L.J.; et al. Relationship Between Urine Bisphenol-A Level and Declining Male Sexual Function. J. Androl. 2010, 31, 500–506. [Google Scholar] [CrossRef]
  40. Meeker, J.D.; Yang, T.; Ye, X.; Calafat, A.M.; Hauser, R. Urinary Concentrations of Parabens and Serum Hormone Levels, Semen Quality Parameters, and Sperm DNA Damage. Environ. Health Perspect. 2011, 119, 252–257. [Google Scholar] [CrossRef] [Green Version]
  41. Goldstone, A.E.; Chen, Z.; Perry, M.J.; Kannan, K.; Louis, G.M. Urinary Bisphenol A and Semen Quality, the LIFE Study. Reprod. Toxicol. 2015, 51, 7–13. [Google Scholar] [CrossRef]
  42. La Rocca, C.; Tait, S.; Guerranti, C.; Busani, L.; Ciardo, F.; Bergamasco, B.; Perra, G.; Mancini, F.R.; Marci, R.; Bordi, G.; et al. Exposure to Endocrine Disruptors and Nuclear Receptors Gene Expression in Infertile and Fertile Men from Italian Areas with Different Environmental Features. Int. J. Environ. Res. Public Health 2015, 12, 12426–12445. [Google Scholar] [CrossRef] [Green Version]
  43. Lian, J.; Zhang, X.; Tian, H.; Liang, N.; Wang, Y.; Liang, C.; Li, X.; Sun, F. Altered MicroRNA Expression in Patients with Non-Obstructive Azoospermia. Reprod. Biol. Endocrinol. 2009, 7, 13. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Wang, C.; Yang, C.; Chen, X.; Yao, B.; Yang, C.; Zhu, C.; Li, L.; Wang, J.; Li, X.; Shao, Y.; et al. Altered Profile of Seminal Plasma MicroRNAs in the Molecular Diagnosis of Male Infertility. Clin. Chem. 2011, 57, 1722–1731. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Wu, W.; Hu, Z.; Qin, Y.; Dong, J.; Dai, J.; Lu, C.; Zhang, W.; Shen, H.; Xia, Y.; Wang, X. Seminal Plasma MicroRNAs: Potential Biomarkers for Spermatogenesis Status. Mol. Hum. Reprod. 2012, 18, 489–497. [Google Scholar] [CrossRef]
  46. Jung, Y.H.; Gupta, M.K.; Shin, J.Y.; Uhm, S.J.; Lee, H.T. MicroRNA Signature in Testes-Derived Male Germ-Line Stem Cells. Mol. Hum. Reprod. 2010, 16, 804–810. [Google Scholar] [CrossRef]
  47. Zhou, R.; Wang, R.; Qin, Y.; Ji, J.; Xu, M.; Wu, W.; Chen, M.; Wu, D.; Song, L.; Shen, H.; et al. Mitochondria-Related miR-151a-5p Reduces Cellular ATP Production by Targeting CYTB in Asthenozoospermia. Sci. Rep. 2015, 5, 17743. [Google Scholar] [CrossRef] [Green Version]
  48. Muñoz, X.; Mata, A.; Bassas, L.; Larriba, S. Altered miRNA Signature of Developing Germ-Cells in Infertile Patients Relates to the Severity of Spermatogenic Failure and Persists in Spermatozoa. Sci. Rep. 2015, 5, 17991. [Google Scholar] [CrossRef] [Green Version]
  49. Veiga-Lopez, A.; Luense, L.J.; Christenson, L.K.; Padmanabhan, V. Developmental Programming: Gestational Bisphenol-A Treatment Alters Trajectory of Fetal Ovarian Gene Expression. Endocrinology 2013, 154, 1873–1884. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  50. Cho, S.; Mutlu, L.; Zhou, Y.; Taylor, H.S. Aromatase Inhibitor Regulates Let-7 Expression and Let-7f-Induced Cell Migration in Endometrial Cells from Women with Endometriosis. Fertil. Steril. 2016, 106, 673–680. [Google Scholar] [CrossRef] [Green Version]
Jcm 10 05945 g001 550
Figure 1. BPA concentrations measured in the seminal plasma of the group of men with non-obstructive azoospermia, the group of men with oligoasthenoteratozoospermia, and the control group of healthy men. The asterisk indicates significant differences between the groups (* p < 0.05). C, control; NOA, non-obstructive azoospermia; O, oligoasthenoteratozoospermia.
Figure 1. BPA concentrations measured in the seminal plasma of the group of men with non-obstructive azoospermia, the group of men with oligoasthenoteratozoospermia, and the control group of healthy men. The asterisk indicates significant differences between the groups (* p < 0.05). C, control; NOA, non-obstructive azoospermia; O, oligoasthenoteratozoospermia.
Jcm 10 05945 g001
Jcm 10 05945 g002a 550Jcm 10 05945 g002b 550
Figure 2. Steroid hormone levels in seminal plasma. (a) estradiol, (b) progesterone, (c) testosterone, and (d) androstenedione concentrations measured in the seminal plasma of the group of men with non-obstructive azoospermia, the group of men with oligoasthenoteratozoospermia, and the control group of healthy men. The asterisk indicates significant differences between the groups (* p < 0.05). A, androstenedione; C, control; E2, estradiol, NOA, non-obstructive azoospermia; O, oligoasthenoteratozoospermia; P4, progesterone; T, testosterone; V, semen sample volume.
Figure 2. Steroid hormone levels in seminal plasma. (a) estradiol, (b) progesterone, (c) testosterone, and (d) androstenedione concentrations measured in the seminal plasma of the group of men with non-obstructive azoospermia, the group of men with oligoasthenoteratozoospermia, and the control group of healthy men. The asterisk indicates significant differences between the groups (* p < 0.05). A, androstenedione; C, control; E2, estradiol, NOA, non-obstructive azoospermia; O, oligoasthenoteratozoospermia; P4, progesterone; T, testosterone; V, semen sample volume.
Jcm 10 05945 g002aJcm 10 05945 g002b
Jcm 10 05945 g003a 550Jcm 10 05945 g003b 550
Figure 3. Expression profile of selected miRNAs in seminal plasma. qPCR analysis of the (a) miR-let-7a, (b) miR-let-7b, (c) miR-let-7c, and (d) miR-518f expression levels in the seminal plasma of the group of men with non-obstructive azoospermia, the group of men with oligoasthenoteratozoospermia, and the control group of healthy men. Asterisk indicates significant differences between the groups (*** p < 0.001). C, control; NOA, non-obstructive azoospermia; O, oligoasthenoteratozoospermia.
Figure 3. Expression profile of selected miRNAs in seminal plasma. qPCR analysis of the (a) miR-let-7a, (b) miR-let-7b, (c) miR-let-7c, and (d) miR-518f expression levels in the seminal plasma of the group of men with non-obstructive azoospermia, the group of men with oligoasthenoteratozoospermia, and the control group of healthy men. Asterisk indicates significant differences between the groups (*** p < 0.001). C, control; NOA, non-obstructive azoospermia; O, oligoasthenoteratozoospermia.
Jcm 10 05945 g003aJcm 10 05945 g003b
Table
Table 1. Characteristics of the semen parameters of men included in the study.
Table 1. Characteristics of the semen parameters of men included in the study.
CharacteristicsControl
(n = 50)		Oligoasthenotera-Tozoospermia
(n = 46)		Azoospermia
(n = 20)		p-Value
Age (years)31.30 ± 0.7731.36 ± 0.8631.20 ± 1.220.966
BMI23.92 ± 0.3523.69 ± 0.3423.3 ± 0.520.608
Volume4.01 ± 0.174.32 ± 0.323.75 ± 0.260.675
Sperm concentration (×106/mL)42.56 ± 4.935.60 ± 0.7200.0001
Total sperm concentration165.85 ± 19.8021.28 ± 2.8500.0001
Total motility (%)74.02 ± 1.8349.03 ± 3.0200.0001
Progressive motility (%)51.45 ± 2.0428.84 ± 2.5400.0001
Normal morphology (%)12.20 ± 1.263.72 ± 0.0400.0001
Data are mean ± SEM. If significant, p-values are highlighted in bold.
Table
Table 2. Pearson’s correlation coefficients of seminal plasma BPA levels with semen quality parameters, steroids, and selected miRNAs.
Table 2. Pearson’s correlation coefficients of seminal plasma BPA levels with semen quality parameters, steroids, and selected miRNAs.
BPA
Parameterrp-value
Sperm concentration−0.2320.01
Total sperm concentration−0.220.02
Total motility−0.1480.11
Progressive motility−0.0680.47
Normal morphology−0.1930.04
E2−0.1460.12
P4−0.0610.51
T−0.0010.99
A−0.1250.18
miR-let-7a0.1890.04
miR-let-7b0.1050.26
miR-let-7c0.2490.007
miR-518f−0.2360.01
If significant, coefficients and p-values are highlighted in bold.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Palak, E.; Lebiedzińska, W.; Anisimowicz, S.; Sztachelska, M.; Pierzyński, P.; Wiczkowski, W.; Żelazowska-Rutkowska, B.; Niklińska, G.N.; Ponikwicka-Tyszko, D.; Wołczyński, S. The Association between Bisphenol A, Steroid Hormones, and Selected MicroRNAs Levels in Seminal Plasma of Men with Infertility. J. Clin. Med. 2021, 10, 5945. https://doi.org/10.3390/jcm10245945

AMA Style

Palak E, Lebiedzińska W, Anisimowicz S, Sztachelska M, Pierzyński P, Wiczkowski W, Żelazowska-Rutkowska B, Niklińska GN, Ponikwicka-Tyszko D, Wołczyński S. The Association between Bisphenol A, Steroid Hormones, and Selected MicroRNAs Levels in Seminal Plasma of Men with Infertility. Journal of Clinical Medicine. 2021; 10(24):5945. https://doi.org/10.3390/jcm10245945

Chicago/Turabian Style

Palak, Ewelina, Weronika Lebiedzińska, Sławomir Anisimowicz, Maria Sztachelska, Piotr Pierzyński, Wiesław Wiczkowski, Beata Żelazowska-Rutkowska, Gabriella Nicole Niklińska, Donata Ponikwicka-Tyszko, and Sławomir Wołczyński. 2021. "The Association between Bisphenol A, Steroid Hormones, and Selected MicroRNAs Levels in Seminal Plasma of Men with Infertility" Journal of Clinical Medicine 10, no. 24: 5945. https://doi.org/10.3390/jcm10245945

APA Style

Palak, E., Lebiedzińska, W., Anisimowicz, S., Sztachelska, M., Pierzyński, P., Wiczkowski, W., Żelazowska-Rutkowska, B., Niklińska, G. N., Ponikwicka-Tyszko, D., & Wołczyński, S. (2021). The Association between Bisphenol A, Steroid Hormones, and Selected MicroRNAs Levels in Seminal Plasma of Men with Infertility. Journal of Clinical Medicine, 10(24), 5945. https://doi.org/10.3390/jcm10245945

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop